BrainStorm Cell Therapeutics
BCLI
#10185
Rank
A$10.84 M
Marketcap
$1.90
Share price
-6.50%
Change (1 day)
-87.16%
Change (1 year)

BrainStorm Cell Therapeutics (BCLI) - Total debt

Total debt on the balance sheet as of September 2024 : A$1.39 Million

According to BrainStorm Cell Therapeutics's latest financial reports the company's total debt is A$1.39 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

BrainStorm Cell Therapeutics - Total debt on balance sheet (from 2002 to 2024)

Total debt by year

Year Total debt Change
2022-12-31A$6.01 M-14.15%
2021-12-31A$7 M-25.36%
2020-12-31A$9.38 M177.74%
2019-12-31A$3.37 M
2018-12-31N/A
2010-12-31A$0.13 M-67.25%
2009-12-31A$0.41 M-34.4%
2008-12-31A$0.62 M-64.38%
2007-12-31A$1.76 M23.4%
2006-12-31A$1.42 M
2006-03-31A$0.7 M
2004-03-31A$0.04 M18.24%
2003-03-31A$0.03 M83.42%
2002-03-31A$0.01 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
A$44.17 B 3,175,999.88%๐Ÿ‡บ๐Ÿ‡ธ USA
A$1.30 B 93,678.48%๐Ÿ‡บ๐Ÿ‡ธ USA
A$0.18 B 13,394.29%๐Ÿ‡บ๐Ÿ‡ธ USA
A$10.96 B 788,282.88%๐Ÿ‡บ๐Ÿ‡ธ USA
A$0.15 B 11,180.62%๐Ÿ‡บ๐Ÿ‡ธ USA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA